Watch Ticker

Ventyx Biosciences, Inc. Common Stock

Go to Ventyx Biosciences, Inc. Common Stock Website

$2.64

-0.08 (-2.94%)

Live

Previous Close

$2.72

Day Range

$2.58 - $2.76

Previous Day Range

$2.6 - $2.745

Market Cap

$187.2 million USD

Day Vol.

471522

Previous Day Vol.

287951

Currency

USD

Primary Exchange

Nasdaq

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline o...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Ventyx Biosciences, Inc. - Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s Disease

Ventyx Biosciences has initiated a Phase 2a trial of its NLRP3 inhibitor VTX3232 in patients with early Parkinson's disease. The trial aims to evaluate the safety, tolerability, and impact of VTX3232 on disease-relevant biomarkers and microglial activation.

Related tickers: VTYX.

Read Full Article

Ventyx Biosciences, Inc. - Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the following upcoming investor conferences:

Related tickers: VTYX.

Read Full Article

Trending Tickers

Please sign in to view